Aleafia to Release Q3 Results on Nov 26, Hold First Ever Results Call
TORONTO, Nov. 12, 2018 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH) (“Aleafia“) or (the “Company“), […]
TSX News -
Bombardier-Alstom consortium to supply 153 additional AZUR metro cars for Montréal
Order valued at approximately $448 million CDN With 60% Canadian content, contract will leverage a network of several hundred suppliers […]
FTI Consulting Bolsters Energy, Power & Products Practice with the Appointment of Senior Business Transformation Expert
Jim Franks Joins as a Senior Managing Director in Dallas WASHINGTON, Nov. 12, 2018 (GLOBE NEWSWIRE) — FTI Consulting, Inc. […]
Pain Therapeutics Appeals FDA Decision on REMOXY
AUSTIN, Texas, Nov. 12, 2018 (GLOBE NEWSWIRE) — Pain Therapeutics, Inc. (Nasdaq: PTIE), a biopharmaceutical company, today announced that it […]
MyoKardia Presents Preclinical Evidence of Mavacamten’s Novel Effect on Diastolic Compliance at the 2018 American Heart Association Scientific Sessions
Improved Left Ventricular Compliance Demonstrated in Genetic Pig Model of Non-Obstructed Hypertrophic Cardiomyopathy Results Add to Growing Body of Evidence […]
New Findings from Pluristem’s Phase II IC study: PLX-PAD Cells Significantly Improves Blood Glucose Control (HbA1c) and Reduce Chronic Inflammation
Additional data from Pluristem’s Phase II IC study were presented at the 2018 American Heart Association Scientific Sessions HAIFA, Israel, […]
Hut 8 Adds 12 Bitcoin Mining BlockBoxes to Drumheller Facility
TORONTO, Nov. 12, 2018 (GLOBE NEWSWIRE) — Hut 8 Mining Corp. (“Hut 8” or the “Company”) (TSXV: HUT) (OTCQX: HUTMF), […]
Auxly Reports Q3 2018 Financial Results and Highlights Key Milestones
VANCOUVER, British Columbia, Nov. 12, 2018 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX.V – XLY) (OTCQX: CBWTF) (“Auxly” or […]
Collegium to Present at Upcoming Investor Conferences
STOUGHTON, Mass., Nov. 12, 2018 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company focused on becoming […]
Aptinyx Exploratory Clinical Studies Provide First Evidence that NYX-2925 Elicits Rapid, Persistent, NMDAr-Mediated Pharmacodynamic Activity in Humans
Studies in Healthy Human Volunteers Reinforce Mechanism of Action Observed in Preclinical Studies EVANSTON, Ill., Nov. 12, 2018 (GLOBE NEWSWIRE) […]
